相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia
Chiara Cerami et al.
NEUROIMAGE-CLINICAL (2015)
Implications of early treatment among Medicaid patients with Alzheimer's disease
David S. Geldmacher et al.
ALZHEIMERS & DEMENTIA (2014)
Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease
Panagiotis Alexopoulos et al.
ALZHEIMERS & DEMENTIA (2014)
FDG-PET and amyloid-PET imaging: the diverging paths
Daniela Perani
CURRENT OPINION IN NEUROLOGY (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia
Pasquale Anthony Della Rosa et al.
NEUROINFORMATICS (2014)
Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy
E. Coppi et al.
NEUROLOGICAL SCIENCES (2014)
Practical utility of amyloid and FDG-PET in an academic dementia center
Pascual Sanchez-Juan et al.
NEUROLOGY (2014)
Improving CSF biomarkers' performance for predicting progression from Mild Cognitive Impairment to Alzheimer's disease by considering different confounding factors: a meta-analysis
Daniel Ferreira et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
Daniela Perani et al.
NEUROIMAGE-CLINICAL (2014)
Impact of molecular imaging on the diagnostic process in a memory clinic
Rik Ossenkoppele et al.
ALZHEIMERS & DEMENTIA (2013)
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Michael W. Weiner et al.
Alzheimers & Dementia (2013)
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease
Manja Lehmann et al.
BRAIN (2013)
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Agneta Nordberg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
Annapaola Prestia et al.
NEUROLOGY (2013)
Imaging markers for Alzheimer disease Which vs how
Giovanni B. Frisoni et al.
NEUROLOGY (2013)
Criteria for the diagnosis of corticobasal degeneration
Melissa J. Armstrong et al.
NEUROLOGY (2013)
Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers
Jennifer L. Shaffer et al.
RADIOLOGY (2013)
Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database
Joseph E. Gaugler et al.
BMC GERIATRICS (2013)
Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies
Koji Kasanuki et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Multimodal classification of Alzheimer's disease and mild cognitive impairment
Daoqiang Zhang et al.
NEUROIMAGE (2011)
Classification of primary progressive aphasia and its variants
M. L. Gorno-Tempini et al.
NEUROLOGY (2011)
Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease
K. B. Walhovd et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
A Comparison of the Diagnostic Sensitivity of MRI, CBF-SPECT, FDG-PET and Cerebrospinal Fluid Biomarkers for Detecting Alzheimer's Disease in a Memory Clinic
Akiyoshi Morinaga et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
The clinical use of structural MRI in Alzheimer disease
Giovanni B. Frisoni et al.
NATURE REVIEWS NEUROLOGY (2010)
Comparing predictors of conversion and decline in mild cognitive impairment
S. M. Landau et al.
NEUROLOGY (2010)
Mild Cognitive Impairment Ten Years Later
Ronald C. Petersen et al.
ARCHIVES OF NEUROLOGY (2009)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
Age, Alzheimer disease, and brain structure
C. A. Raji et al.
NEUROLOGY (2009)
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease
Yi Li et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
The significance of medial temporal lobe atrophy
F. Barkhof et al.
NEUROLOGY (2007)
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Norman L. Foster et al.
BRAIN (2007)
FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment
Andreas Fellgiebel et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2007)
Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study
P. Edison et al.
NEUROLOGY (2007)
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Leslie M. Shaw et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Hippocampal atrophy in Alzheimer disease: Age matters
LA van de Pol et al.
NEUROLOGY (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease
D Anchisi et al.
ARCHIVES OF NEUROLOGY (2005)
Cognition and anatomy in three variants of primary progressive aphasia
ML Gorno-Tempini et al.
ANNALS OF NEUROLOGY (2004)
Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia
E Salmon et al.
NEUROIMAGE (2003)
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
K Herholz et al.
NEUROIMAGE (2002)
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia
CR Jack et al.
NEUROLOGY (2002)